Dépôt numérique

MMP-9 expression varies according to molecular subtypes of breast cancer


Téléchargements par mois depuis la dernière année

Plus de statistiques...

Yousef, Einas M, Tahir, Muhammad R, St-Pierre, Yves et Gaboury, Louis (2014). MMP-9 expression varies according to molecular subtypes of breast cancer BMC Cancer , vol. 14 , nº 609. p. 1-12. DOI: 10.1186/1471-2407-14-609.

[thumbnail of 12885_2014_Article_4789.pdf]
Disponible sous licence Creative Commons Public Domain Dedication.

Télécharger (2MB) | Prévisualisation


BACKGROUND: In 2014, breast cancer remains a major cause of mortality worldwide mostly due to tumor relapse and metastasis. There is currently a great interest in identifying cancer biomarkers and signalling pathways mechanistically related to breast cancer progression. Matrix metalloproteinase-9 (MMP-9) is a member of matrix degrading enzymes involved in cancer development, invasion and metastasis. Our objective was to investigate MMP-9 expression in normal human breast tissue and to compare it to that of breast cancer of various histological grades and molecular subtypes. We also sought to correlate MMP-9 expression with the incidence of metastasis, survival rates and relapse in breast cancer patients. METHODS: MMP-9 was first studied using in silico analysis on available DNA microarray and RNA sequencing data of human breast cancer tissues and human breast cancer cell lines. We next ascertained MMP-9 expression in both normal breast tissue and in human breast carcinoma tissue microarrays. RESULTS: Significant increase in MMP-9 expression was found in breast cancer cells where compared to normal breast tissue. A positive correlation could also be established between elevated levels of MMP-9 and breast cancer of high histological grade. Furthermore, our results indicate that not only MMP-9 is differentially expressed between each molecular subset but also, more importantly MMP-9 overexpression revealed itself as a startling feature of triple-negative and HER2-positive breast cancers. Lastly, the clinical relevance of MMP-9 overexpression is strongly supported by its significant association with a higher incidence of metastasis and relapse. CONCLUSIONS: Differential expression of MMP-9 reflects the extent of cellular differentiation in breast cancer cells and is closely related to the most aggressive subtypes of breast cancer. Hence, MMP-9 is a promising prognostic biomarker of high-grade breast cancer. In our opinion, MMP-9 expression could help segregate subsets of aggressive breast cancer into clinically meaningful subtypes.

Type de document: Article
Mots-clés libres: MMP-9 Human breast cancers Metastasis In silico analysis Tissue microarrays
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 09 mars 2016 15:46
Dernière modification: 22 déc. 2016 16:42
URI: https://espace.inrs.ca/id/eprint/3134

Actions (Identification requise)

Modifier la notice Modifier la notice